Cargando…

Neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: A longitudinal case–control study

BACKGROUND AND AIM: Innate immune disarray is a key component in the development and progression of acute on chronic liver failure (ACLF) and predisposition to infections. We evaluated the neutrophil dysfunction and its impact on outcomes in patients with ACLF. METHODS: Forty patients with acute dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Makkar, Kunaal, Tomer, Shallu, Verma, Nipun, Rathi, Sahaj, Arora, Sunil K, Taneja, Sunil, Duseja, Ajay, Chawla, Yogesh K, Dhiman, Radha K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411642/
https://www.ncbi.nlm.nih.gov/pubmed/32782944
http://dx.doi.org/10.1002/jgh3.12344
_version_ 1783568425653633024
author Makkar, Kunaal
Tomer, Shallu
Verma, Nipun
Rathi, Sahaj
Arora, Sunil K
Taneja, Sunil
Duseja, Ajay
Chawla, Yogesh K
Dhiman, Radha K
author_facet Makkar, Kunaal
Tomer, Shallu
Verma, Nipun
Rathi, Sahaj
Arora, Sunil K
Taneja, Sunil
Duseja, Ajay
Chawla, Yogesh K
Dhiman, Radha K
author_sort Makkar, Kunaal
collection PubMed
description BACKGROUND AND AIM: Innate immune disarray is a key component in the development and progression of acute on chronic liver failure (ACLF) and predisposition to infections. We evaluated the neutrophil dysfunction and its impact on outcomes in patients with ACLF. METHODS: Forty patients with acute decompensation of cirrhosis (10 each of grades 0, 1, 2, and 3 ACLF) and 10 healthy controls were prospectively evaluated for neutrophil immunophenotype (NP), neutrophil phagocytic capacity (NPC), and oxidative burst (OB) in both resting and stimulated conditions. The patients were followed up for 90 days or until death or transplant, whichever was earlier. RESULTS: NP was normal (in %) and NPC (in mean fluorescence intensity [MFI]) was better in controls compared to patients with ACLF (83.74 ± 12.38 vs 63.84 ± 22.98; P = 0.007 and 98.33 ± 130.60 vs 18.73 ± 17.88, P = 0.001, respectively). Resting OB was higher in patients with ACLF compared to controls (97 ± 4.9% vs 91 ± 9%; P = 0.034), but it failed to increase further after stimulation, suggesting an immune exhaustion. NP was normal (in %) and NPC (in MFI) was better in 90‐day survivors compared to nonsurvivors (78 ± 11.9 vs 62.2 ± 24.11, P = 0.02 and 33.3 ± 22.7 vs 16.36 ± 13.3; P = 0.004, respectively). Phenotypically normal neutrophils >71.7% had 78.6% sensitivity and 65.4% specificity with an area under receiver operating curve (AUROC) of 0.70 (95% confidence interval [CI]: 0.55–0.90); P = 0.017, and NPC >17.32. MFI had 71.4% sensitivity and 69.6% specificity with an AUROC of 0.73 (95% CI: 0.54–0.86), P = 0.035, in predicting 90‐day survival. CONCLUSION: Neutrophils have impaired bactericidal function in patients with ACLF compared to healthy adults. Neutrophil phenotype and phagocytic capacity may be used to predict 90‐day survival in patients with ACLF.
format Online
Article
Text
id pubmed-7411642
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wiley Publishing Asia Pty Ltd
record_format MEDLINE/PubMed
spelling pubmed-74116422020-08-10 Neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: A longitudinal case–control study Makkar, Kunaal Tomer, Shallu Verma, Nipun Rathi, Sahaj Arora, Sunil K Taneja, Sunil Duseja, Ajay Chawla, Yogesh K Dhiman, Radha K JGH Open Original Articles BACKGROUND AND AIM: Innate immune disarray is a key component in the development and progression of acute on chronic liver failure (ACLF) and predisposition to infections. We evaluated the neutrophil dysfunction and its impact on outcomes in patients with ACLF. METHODS: Forty patients with acute decompensation of cirrhosis (10 each of grades 0, 1, 2, and 3 ACLF) and 10 healthy controls were prospectively evaluated for neutrophil immunophenotype (NP), neutrophil phagocytic capacity (NPC), and oxidative burst (OB) in both resting and stimulated conditions. The patients were followed up for 90 days or until death or transplant, whichever was earlier. RESULTS: NP was normal (in %) and NPC (in mean fluorescence intensity [MFI]) was better in controls compared to patients with ACLF (83.74 ± 12.38 vs 63.84 ± 22.98; P = 0.007 and 98.33 ± 130.60 vs 18.73 ± 17.88, P = 0.001, respectively). Resting OB was higher in patients with ACLF compared to controls (97 ± 4.9% vs 91 ± 9%; P = 0.034), but it failed to increase further after stimulation, suggesting an immune exhaustion. NP was normal (in %) and NPC (in MFI) was better in 90‐day survivors compared to nonsurvivors (78 ± 11.9 vs 62.2 ± 24.11, P = 0.02 and 33.3 ± 22.7 vs 16.36 ± 13.3; P = 0.004, respectively). Phenotypically normal neutrophils >71.7% had 78.6% sensitivity and 65.4% specificity with an area under receiver operating curve (AUROC) of 0.70 (95% confidence interval [CI]: 0.55–0.90); P = 0.017, and NPC >17.32. MFI had 71.4% sensitivity and 69.6% specificity with an AUROC of 0.73 (95% CI: 0.54–0.86), P = 0.035, in predicting 90‐day survival. CONCLUSION: Neutrophils have impaired bactericidal function in patients with ACLF compared to healthy adults. Neutrophil phenotype and phagocytic capacity may be used to predict 90‐day survival in patients with ACLF. Wiley Publishing Asia Pty Ltd 2020-05-05 /pmc/articles/PMC7411642/ /pubmed/32782944 http://dx.doi.org/10.1002/jgh3.12344 Text en © 2020 The Authors. JGH Open: An open access journal of gastroenterology and hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Makkar, Kunaal
Tomer, Shallu
Verma, Nipun
Rathi, Sahaj
Arora, Sunil K
Taneja, Sunil
Duseja, Ajay
Chawla, Yogesh K
Dhiman, Radha K
Neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: A longitudinal case–control study
title Neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: A longitudinal case–control study
title_full Neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: A longitudinal case–control study
title_fullStr Neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: A longitudinal case–control study
title_full_unstemmed Neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: A longitudinal case–control study
title_short Neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: A longitudinal case–control study
title_sort neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: a longitudinal case–control study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411642/
https://www.ncbi.nlm.nih.gov/pubmed/32782944
http://dx.doi.org/10.1002/jgh3.12344
work_keys_str_mv AT makkarkunaal neutrophildysfunctionpredicts90daysurvivalinpatientswithacuteonchronicliverfailurealongitudinalcasecontrolstudy
AT tomershallu neutrophildysfunctionpredicts90daysurvivalinpatientswithacuteonchronicliverfailurealongitudinalcasecontrolstudy
AT vermanipun neutrophildysfunctionpredicts90daysurvivalinpatientswithacuteonchronicliverfailurealongitudinalcasecontrolstudy
AT rathisahaj neutrophildysfunctionpredicts90daysurvivalinpatientswithacuteonchronicliverfailurealongitudinalcasecontrolstudy
AT arorasunilk neutrophildysfunctionpredicts90daysurvivalinpatientswithacuteonchronicliverfailurealongitudinalcasecontrolstudy
AT tanejasunil neutrophildysfunctionpredicts90daysurvivalinpatientswithacuteonchronicliverfailurealongitudinalcasecontrolstudy
AT dusejaajay neutrophildysfunctionpredicts90daysurvivalinpatientswithacuteonchronicliverfailurealongitudinalcasecontrolstudy
AT chawlayogeshk neutrophildysfunctionpredicts90daysurvivalinpatientswithacuteonchronicliverfailurealongitudinalcasecontrolstudy
AT dhimanradhak neutrophildysfunctionpredicts90daysurvivalinpatientswithacuteonchronicliverfailurealongitudinalcasecontrolstudy